News
9h
Mining Technology on MSNCanada introduces new steel tariffs to protect domestic steel industryEffective from 1 August 2025, the quota will apply to countries with which Canada has free trade agreements, excluding the US ...
Following today’s release of DFS’ figures for the 52 weeks ending 29 June 2025; Matt Walton, senior retail analyst at ...
Localising and automating supply chains will allow companies to mitigate the impact of tariffs and minimise resulting costs.
10d
Just Auto on MSNGovernment subsidies drive China’s vehicle market up – GlobalData"Government subsidies drive China’s vehicle market up – GlobalData" was originally created and published by Just Auto, a ...
(Alliance News) - GlobalData PLC on Tuesday said its process for move to London's Main Market away from the AIM Market is underway, as it highlighted continued investment in Growth Transformation Plan ...
2d
GlobalData on MSNCaranx Medical’s AI TAVI-TAVR software gains FDA approvalThe US Food and Drug Administration (FDA) has cleared Caranx Medical’s TAVIPILOT Soft, an artificial intelligence (AI)-based guide software for use during Transcatheter Aortic Valve Implantation (TAVI ...
Experian (EXPN), Barratt Redrow (BTRW), B&M European Value (BME), GlobalData (DATA), Robert Walters (RWA), Mobico (MCG), ...
Walmart and its banking partner Mastercard have created a new payment system for international money transfers, data ...
Artificial intelligence, robotics and the Internet of Things (IoT) are no longer futuristic concepts—they are reshaping how consumer brands operate, engage and grow. As these technologies move from ...
7d
Pharmaceutical Technology on MSNCTO East Coast 2025: Global oncology cell therapy market to hit $25bn by 2031The US dominates overall sales, yet GlobalData predicts that China is shaping up to be a formidable presence in the cell therapy space.
13d
Clinical Trials Arena on MSNNovartis’ Cosentyx shows no benefit in Phase III GCA trialNovartis’ Cosentyx (secukinumab) has failed to show any benefit in the Phase III study in adults with newly diagnosed or relapsing giant cell arteritis (GCA). In the GCAptAIN trial (NCT04930094), ...
2d
GlobalData on MSNKirkland & Ellis leads M&A legal advisory ranking in H1 2025Kirkland & Ellis has been identified as the leading legal adviser in mergers and acquisitions (M&A) for the first half of 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results